Phenotype | Head | Coil1A | Coil1B | Coil2A | Coil2B | Ig-like | L12 | L2 | L2N | Tail |
L-CMD (n=41) | 8 (19.5%) | 4 (9.8%) | 1 (2.4%) | 13 (31.7%) | 5 (12.2%) | 6 (14.6%) | 0 | 0 | 4 (9.8%) | 0 |
EDMD (n=32) | 3 (9.4%) | 2 (6.3%) | 1 (3.1%) | 2 (6.3%) | 10 (31.4%) | 11 (34.4%) | 0 | 2 (6.3%) | 1 (3.1%) | 0 |
LGMD1B (n=11) | 1 (9.1%) | 0 | 0 | 0 | 3 (27.3%) | 4 (36.3%) | 1 (9.1%) | 0 | 2 (18.2%) | 0 |
Total (n=84) | 12 (14.3%) | 6 (7.1%) | 2 (2.4%) | 15 (17.9%) | 18 (21.4%) | 21 (25.0%) | 1 (1.2%) | 2 (2.4%) | 7 (8.3%) | 0 |
EDMD, Emery-Dreifuss muscular dystrophy; Ig, immunoglobulin; L2, Linker of coil 2A and 2B; L12, linker of coil 1B and 2A; L-CMD, LMNA-related congenital muscular dystrophy; LGMD1B, limb-girdle muscular dystrophy type 1B; L2N, linker of coil 2B and NLS; NLS, nuclear location signal.